Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 41 studies | 51% ± 24% | |
| pericyte | 29 studies | 50% ± 23% | |
| smooth muscle cell | 21 studies | 52% ± 26% | |
| connective tissue cell | 15 studies | 52% ± 18% | |
| endothelial cell of lymphatic vessel | 13 studies | 33% ± 15% | |
| myofibroblast cell | 10 studies | 40% ± 17% | |
| endothelial cell | 9 studies | 27% ± 10% | |
| vein endothelial cell | 7 studies | 29% ± 12% | |
| endothelial cell of artery | 7 studies | 32% ± 10% | |
| mesothelial cell | 4 studies | 56% ± 28% | |
| retinal pigment epithelial cell | 4 studies | 58% ± 18% | |
| adventitial cell | 4 studies | 77% ± 14% | |
| adipocyte | 3 studies | 38% ± 23% | |
| endothelial cell of vascular tree | 3 studies | 31% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 99% | 1405.58 | 644 / 653 | 90% | 14.91 | 543 / 605 |
| breast | 98% | 2516.58 | 452 / 459 | 85% | 13.69 | 951 / 1118 |
| lung | 99% | 1601.18 | 571 / 578 | 83% | 8.54 | 957 / 1155 |
| adrenal gland | 84% | 469.62 | 217 / 258 | 91% | 20.13 | 210 / 230 |
| prostate | 87% | 1032.78 | 212 / 245 | 83% | 10.54 | 418 / 502 |
| bladder | 95% | 1601.95 | 20 / 21 | 71% | 7.52 | 357 / 504 |
| esophagus | 86% | 1199.03 | 1236 / 1445 | 74% | 6.89 | 136 / 183 |
| skin | 94% | 1140.79 | 1708 / 1809 | 62% | 6.23 | 294 / 472 |
| kidney | 66% | 337.87 | 59 / 89 | 87% | 20.98 | 788 / 901 |
| uterus | 92% | 970.70 | 157 / 170 | 59% | 9.22 | 273 / 459 |
| intestine | 72% | 586.77 | 691 / 966 | 69% | 7.19 | 362 / 527 |
| stomach | 59% | 473.13 | 211 / 359 | 71% | 8.63 | 204 / 286 |
| brain | 14% | 53.91 | 358 / 2642 | 89% | 8.87 | 629 / 705 |
| pancreas | 3% | 11.50 | 10 / 328 | 97% | 19.16 | 173 / 178 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.83 | 1 / 1 |
| adipose | 100% | 2883.33 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 2035.71 | 1319 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 1830.85 | 843 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 7.89 | 26 / 29 |
| ovary | 33% | 261.24 | 59 / 180 | 54% | 3.84 | 232 / 430 |
| liver | 3% | 12.12 | 7 / 226 | 71% | 10.13 | 289 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 60% | 3.84 | 27 / 45 |
| eye | 0% | 0 | 0 / 0 | 55% | 3.86 | 44 / 80 |
| muscle | 42% | 207.32 | 339 / 803 | 0% | 0 | 0 / 0 |
| spleen | 8% | 30.65 | 19 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 1.62 | 5 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PLAC9 |
| Protein name | Placenta associated 9 (Placenta-specific 9, isoform CRA_b) Placenta-specific protein 9 Placenta associated 9 |
| Synonyms | hCG_22687 |
| Description | |
| Accessions | Q5JTB5 Q5JTB6 Q5JTB4 ENST00000372267.6 ENST00000372270.6 ENST00000372263.4 |